v3 Template
L
Lykos Therapeutics
Mental Healthcare
Founded
--
Employees
--
Total Funding
$100.0M
Funding Rounds
1
Last Funding
2024-01-05
About Lykos Therapeutics
Lykos Therapeutics is a public benefit corporation dedicated to transforming mental healthcare by developing investigational psychedelics for therapeutic approaches, with an initial focus on post-traumatic stress disorder (PTSD). Their mission is to make mental healthcare accessible to all, destigmatize conversations about mental health, and address unmet needs through innovative tools and evidence-based research.
Products & Services
Investigational Psychedelics for Mental Health:Developing psychedelics to catalyze therapeutic approaches for mental health conditions, particularly PTSD.
MDMA-Assisted Therapy:An investigational treatment for PTSD, with an expanded access program authorized by the FDA for up to 50 patients (now fully enrolled).
Specialties
Investigational Psychedelics
MDMA-Assisted Therapy
Post-Traumatic Stress Disorder (PTSD) Treatment
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 100000000 MR: - FA: more than $100 million FAN: 100000000 |
D: 2024-01-05 FD: 2024-01-05 |
6 investors |
Series A
Latest
2024-01-05
$100.0M
6 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Lykos Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- lykospbc.com
- Industries
- Mental Healthcare
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro